Literature DB >> 3972284

Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy?

J V Bokhman, O F Chepick, A T Volkova, A S Vishnevsky.   

Abstract

The data on 19 cases of primary endometrial carcinoma, stage I (mean age 28.0 years), cured by the administration of hydroxyprogesterone caproate without surgery and radiation therapy are presented. Clinical recovery in 15 cases was confirmed by repeated cytological and histological examinations of the endometrium. Hydroxyprogesterone caproate dose per course ranged within 25.0-83.0 g. In 4 patients with moderately differentiated cancer (G2), hormonal treatment was carried out in combination with chemotherapy. When tumor regression was confirmed histologically, steroid contraceptives were administered to induce an artificial menstrual cycle. At the closing stage of therapy clomiphene citrates were given in succession to restore the ovulatory cycle. Perspectives of administration of progestogens in young women with stage I endometrial carcinoma as a separate method of therapy are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3972284     DOI: 10.1016/0090-8258(85)90135-0

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  9 in total

1.  Controversies in the management of endometrial carcinoma.

Authors:  Ying Zhang; Jian Wang
Journal:  Obstet Gynecol Int       Date:  2010-06-22

2.  Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate.

Authors:  K Niwa; Y Yokoyama; T Tanaka; T Murase; S Morishita; M Itoh; N Itoh; K Shimokawa; T Tamaya
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

3.  Absence of progesterone receptors in a failed case of fertility-sparing treatment in early endometrial cancer: a case report.

Authors:  Anna V Hoekstra; J Julie Kim; Pacita Keh; Julian C Schink
Journal:  J Reprod Med       Date:  2008-11       Impact factor: 0.142

4.  Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment.

Authors:  Gabriella Macchia; Francesco Deodato; Savino Cilla; Francesco Legge; Vito Carone; Vito Chiantera; Vincenzo Valentini; Alessio Giuseppe Morganti; Gabriella Ferrandina
Journal:  Oncol Lett       Date:  2016-03-29       Impact factor: 2.967

Review 5.  Conservative management of patients with early endometrial carcinoma: a systematic review.

Authors:  Luis Chiva de Agustín; Fernando Lapuente Sastre; Virginia Corraliza Galán; Luis Granados Galainena; Antonio González Martín; Lucía González Cortijo; Natalia Carballo González
Journal:  Clin Transl Oncol       Date:  2008-03       Impact factor: 3.405

Review 6.  Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.

Authors:  Tanri Shiozawa; Ikuo Konishi
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.850

7.  Endometrial adenocarcinoma in a 27-year-old woman.

Authors:  Anis Fadhlaoui; Jamel Ben Hassouna; Mohamed Khrouf; Fethi Zhioua; Anis Chaker
Journal:  Clin Med Insights Case Rep       Date:  2010-08-12

8.  Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesis.

Authors:  Y G Lin; J Shen; E Yoo; R Liu; H-Y Yen; A Mehta; A Rajaei; W Yang; P Mhawech-Fauceglia; F J DeMayo; J Lydon; P Gill; A S Lee
Journal:  Oncogene       Date:  2015-02-16       Impact factor: 9.867

Review 9.  Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia.

Authors:  Qing Zhang; Gonghua Qi; Margaux J Kanis; Ruifen Dong; Baoxia Cui; Xingsheng Yang; Beihua Kong
Journal:  Oncotarget       Date:  2017-05-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.